PHAT — PHATHOM PHARMACEUTICALS INC
什么是 13F 持仓报告?谁需要申报、何时申报 · 13F 持仓报告看不到什么
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
截至Q2 2026,共 171 家机构在其最新 13F 申报中持有 PHAT(PHATHOM PHARMACEUTICALS INC),合计申报市值 $823.49M,对应 75.96M 股。按股数计算较上季度增持 1.4%(+977.09K 股),申报市值环比下降 1.0%。持仓集中度较高:前五大持有人占申报市值的 42.1%,前十大的集中度为 60.0%。
与上一季度相比,24 家新建仓位、61 家加仓、52 家减仓、34 家清仓退出。13F 数据为季末快照,以上变动反映的是 Q2 2026 末的持仓状态,并非实时交易。
PHATHOM PHARMACEUTICALS INC(PHAT)的主要机构持有人包括 Frazier Life Sciences Management, L.P.、Medicxi Ventures Management (Jersey) Ltd、Vanguard Group,按 13F 申报市值在本页 320 家持有人中排名居前。
PHAT 属于Health Care板块。
本页所有数据均来自美国证监会(SEC)13F 季度申报。13F 申报人需在季度结束后 45 天内披露 10 万美元以上的多头持仓;空头、期权对冲与季度内交易不在其列,因此这些数字反映的是机构持仓的季度快照,而非实时仓位。
机构逐季持仓趋势
| 季度 | 持有机构数 | 股数 | 金额 | 环比净变动 |
|---|---|---|---|---|
| Q3 2026 | 110 | 39.04M | $281.68M | -0.1% |
| Q2 2026 | 171 | 75.96M | $823.49M | +1.4% |
| Q1 2026 | 181 | 73.32M | $814.14M | +9.6% |
| Q4 2025 | 177 | 64.01M | $1.06B | -9.2% |
| Q3 2025 | 138 | 68.33M | $803.92M | +10.1% |
| Q2 2025 | 125 | 60.81M | $582.88M | +8.2% |
| Q1 2025 | 139 | 64.87M | $406.49M | +2.9% |
| Q4 2024 | 143 | 66.38M | $538.60M | +1.4% |
表内 8 个季度中,机构持股合计减少 41%(Q4 2024 → Q3 2026);单季变动最大的是 Q3 2025(+10.1%)。
前 25 大机构持仓人(Q3 2026) — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 7.46M | $54.49M | 43.02% | 持有 | |
| 5.25M | $38.30M | 0.00% | 增持 | |
| 3.50M | $25.53M | 0.30% | 持有 | |
| 2.94M | $21.48M | 0.16% | 增持 | |
| 2.74M | $19.97M | 0.00% | 增持 | |
| 2.13M | $15.54M | 0.13% | 减持 | |
| 2.00M | $14.58M | 0.00% | 增持 | |
| 1.88M | $13.74M | 6.55% | 增持 | |
| 2.41M | $13.67M | 0.00% | 增持 | |
| 1.33M | $9.74M | 0.00% | 增持 | |
| 1.11M | $8.07M | 4.28% | 增持 | |
| 813.98K | $5.94M | 0.01% | 减持 | |
| 679.32K | $4.96M | 0.00% | 减持 | |
| 394.31K | $2.88M | 0.00% | 增持 | |
| 376.38K | $2.75M | 0.00% | 增持 | |
| 276.83K | $2.02M | 0.34% | 增持 | |
| 273.77K | $2.01M | 0.00% | 减持 | |
| 249.27K | $1.82M | 0.03% | 持有 | |
| 196.29K | $1.43M | 0.00% | 增持 | |
| 189.19K | $1.38M | 0.00% | 减持 | |
| 100.00K | $1.25M | 0.96% | 增持 | |
| 162.54K | $1.19M | 0.26% | 增持 | |
| 156.31K | $1.14M | 0.00% | 增持 | |
| 140.60K | $1.03M | 0.00% | 增持 | |
| 134.12K | $979.05K | 0.00% | 增持 |
更早季度的机构持仓记录(逐季列表): 返回前 25 大机构持仓人
Q2 2026 — 25 家基金
Q1 2026 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 12.47M | $138.50M | 3.56% | 持有 | |
| 7.46M | $82.93M | 8.45% | 持有 | |
| 4.32M | $48.02M | 0.01% | 增持 | |
| 4.06M | $45.13M | 0.00% | 增持 | |
| 4.02M | $44.69M | 0.02% | 增持 | |
| 4.02M | $44.69M | 0.06% | 增持 | |
| 3.50M | $38.85M | 0.37% | 持有 | |
| 2.58M | $28.70M | 0.00% | 新进 | |
| 1.96M | $21.78M | 1.24% | 持有 | |
| 1.85M | $20.55M | 1.29% | 增持 | |
| 1.63M | $18.08M | 0.03% | 减持 | |
| 1.49M | $16.60M | 7.19% | 增持 | |
| 1.42M | $15.79M | 0.14% | 增持 | |
| 1.39M | $15.41M | 0.00% | 增持 | |
| 1.34M | $14.90M | 0.10% | 增持 | |
| 1.33M | $14.76M | 0.00% | 增持 | |
| 1.21M | $13.39M | 0.02% | 新进 | |
| 995.88K | $11.06M | 0.41% | 增持 | |
| 994.50K | $11.05M | 0.00% | 新进 | |
| 925.00K | $10.28M | 0.22% | 新进 | |
| 860.69K | $9.56M | 0.01% | 新进 | |
| 841.27K | $9.35M | 5.90% | 增持 | |
| 666.03K | $7.40M | 0.00% | 新进 | |
| 626.20K | $6.96M | 0.00% | 增持 | |
| 625.00K | $6.94M | 0.33% | 新进 |
Q4 2025 — 25 家基金
Q3 2025 — 25 家基金
Q2 2025 — 25 家基金
| 基金 | 股数 | 金额 | 组合权重 | 变化 |
|---|---|---|---|---|
| 12.47M | $119.55M | 4.78% | 增持 | |
| 7.46M | $71.59M | 16.75% | 持有 | |
| 4.14M | $39.70M | 0.01% | 增持 | |
| 3.50M | $33.53M | 0.67% | 持有 | |
| 3.32M | $31.79M | 0.00% | 持有 | |
| 2.79M | $26.73M | 0.00% | 持有 | |
| 2.52M | $24.17M | 0.04% | 持有 | |
| 2.25M | $21.58M | 0.04% | 增持 | |
| 2.25M | $21.58M | 0.01% | 增持 | |
| 2.10M | $20.19M | 1.65% | 增持 | |
| 1.96M | $18.80M | 1.42% | 持有 | |
| 1.46M | $14.02M | 0.07% | 减持 | |
| 1.17M | $11.19M | 8.50% | 持有 | |
| 1.07M | $10.26M | 0.00% | 增持 | |
| 1.06M | $10.21M | 2.05% | 增持 | |
| 1.05M | $10.05M | 0.09% | 减持 | |
| 922.93K | $8.85M | 10.80% | 减持 | |
| 849.42K | $8.15M | 0.00% | 减持 | |
| 672.29K | $6.45M | 1.35% | 新进 | |
| 600.00K | $5.75M | 0.11% | 新进 | |
| 521.93K | $5.01M | 0.25% | 减持 | |
| 517.25K | $4.96M | 0.01% | 减持 | |
| 422.08K | $4.05M | 8.03% | 持有 | |
| 419.47K | $4.02M | 0.00% | 减持 | |
| 380.10K | $3.65M | 0.11% | 新进 |
新建仓(Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 1.32M 股 · $14.28M
- Point72 Asset Management 1.02M 股 · $11.09M
- HSBC HOLDINGS PLC 709.70K 股 · $7.70M
- Sixth Street Partners Management Company, L.P. 419.09K 股 · $4.55M
- Opaleye Management Inc. 185.59K 股 · $2.01M
- Jones Hill Capital LP 161.49K 股 · $1.75M
- SCHRODER INVESTMENT MANAGEMENT GROUP 101.75K 股 · $1.11M
- Arrowstreet Capital 77.32K 股 · $838.88K
- Pale Fire Capital SE 49.71K 股 · $539.39K
- Quantbot Technologies LP 42.76K 股 · $463.89K
- NOMURA HOLDINGS INC 40.00K 股 · $434.00K
- Y-Intercept (Hong Kong) Ltd 39.84K 股 · $432.32K
完全清仓(较上季)
- STATE STREET CORP 卖出 1.39M 股 · $15.41M
- Susquehanna Portfolio Strategies, LLC 卖出 267.96K 股 · $2.98M
- Catalio Capital Management, LP 卖出 247.77K 股 · $2.75M
- Balyasny Asset Management 卖出 95.30K 股 · $1.06M
- Freestone Grove Partners LP 卖出 84.57K 股 · $939.61K
- HUSSMAN STRATEGIC ADVISORS, INC. 卖出 84.00K 股 · $933.24K
- Burkehill Global Management, LP 卖出 75.00K 股 · $833.25K
- Aquatic Capital Management LLC 卖出 40.85K 股 · $453.87K
- ALGERT GLOBAL LLC 卖出 39.42K 股 · $437.96K
- VARCOV Co. 卖出 39.17K 股 · $435.21K
- TUDOR INVESTMENT CORP ET AL 卖出 38.23K 股 · $424.68K
- LOS ANGELES CAPITAL MANAGEMENT LLC 卖出 24.68K 股 · $274.15K
基金持仓历史 — 各季度股数(前 20 只基金)
| 基金 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 7.46M | 7.46M | 7.46M | 7.46M | 7.46M | 7.46M | 7.46M | 7.46M | 7.46M | 7.46M | 7.46M | 3.76M | 3.76M | — | — | — | — | — | — | — |
| BlackRock Inc | 5.25M | 4.53M | 4.06M | 3.56M | 3.40M | 3.32M | 3.32M | 3.50M | 3.12M | — | — | — | — | — | — | — | — | — | — | — |
| Carlyle Group Inc. | 3.50M | 3.50M | 3.50M | 3.50M | 3.50M | 3.50M | 3.50M | 3.50M | 3.50M | 3.50M | 3.50M | 3.50M | 3.50M | — | — | — | — | — | — | — |
| WASATCH ADVISORS LP | 2.94M | 1.31M | 1.34M | 1.33M | 1.54M | 1.46M | 1.70M | 1.56M | 246.94K | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.74M | 2.66M | 2.58M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| GW&K Investment Management, LLC | 2.13M | 2.17M | 1.42M | 1.31M | 1.14M | 1.05M | 1.10M | 1.10M | 1.13M | 600.44K | 568.03K | 561.49K | 577.45K | — | — | — | — | — | — | — |
| STATE STREET CORP | 2.00M | — | 1.39M | 1.15M | 1.05M | 849.42K | 901.35K | 1.04M | 922.79K | 785.25K | 717.20K | 687.84K | 667.60K | — | — | — | — | — | — | — |
| Catalys Pacific, LLC | 1.88M | 1.49M | 1.49M | 1.43M | 1.17M | 1.17M | 1.17M | 1.17M | 1.12M | 721.96K | 721.96K | 721.96K | — | — | — | — | — | — | — | — |
| Franklin Resources | 2.41M | 1.97M | 994.50K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 1.33M | 1.32M | 1.33M | 1.07M | 1.09M | 1.07M | 1.02M | 1.02M | 862.92K | 806.05K | 751.38K | 735.27K | 682.57K | 490.12K | 448.61K | 435.04K | 402.29K | 346.94K | 313.82K | 293.20K |
| Propel Bio Management, LLC | 1.11M | 1.05M | 841.27K | 740.92K | 552.93K | 922.93K | 1.13M | 989.93K | 869.93K | 869.93K | 869.93K | 443.05K | — | — | — | — | — | — | — | — |
| Ensign Peak Advisors, Inc | 813.98K | 1.05M | 1.63M | 2.35M | 2.50M | 2.52M | 2.51M | 2.53M | 2.58M | 2.24M | 2.28M | 2.28M | 1.73M | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 679.32K | 796.63K | 666.03K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 394.31K | 354.57K | 338.71K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| UBS Group AG | 376.38K | 204.57K | 360.37K | 304.38K | 338.36K | 419.47K | 707.58K | 465.62K | 71.94K | 43.09K | 49.92K | 39.43K | 33.70K | 16.81K | — | 795 | 628 | — | — | 1.33K |
| Jones Hill Capital LP | 276.83K | 161.49K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| JPMorgan Chase & Co | 273.77K | 275.25K | 287.43K | 296.68K | 136.95K | 138.52K | 137.39K | 136.91K | 135.43K | 134.36K | 138.45K | 146.04K | 144.76K | 134.00K | 114.79K | 129.15K | 171.37K | 170.79K | 175.56K | 172.56K |
| Simplify Asset Management Inc. | 249.27K | 249.27K | 262.39K | 321.94K | 321.94K | 521.93K | 681.93K | 581.93K | 521.93K | 521.93K | 521.93K | 237.94K | 237.94K | — | — | — | — | — | — | — |
| BNP PARIBAS FINANCIAL MARKETS | 196.29K | 8.69K | 11.33K | 9.79K | 8.83K | 5.07K | 2.95K | 39.53K | — | — | — | — | — | — | — | — | — | — | — | — |
| NewEdge Advisors, LLC | 189.19K | 203.96K | 183.00K | 200.82K | 201.52K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ 低买(基金新建/增持,下一季股价上涨 ≥5%) ▼ 高卖(基金减持,下一季股价下跌 ≥5%)
拖拽/滚轮缩放 · 默认显示最近一年 · 标注来自 13F 申报中的季度基金操作 · 悬停查看详情
常见问题
Which funds hold PHAT?
As of 2026-Q2, 171 institutional funds reported holding PHAT (PHATHOM PHARMACEUTICALS INC) in SEC 13F filings, with a combined reported value of $823.49M.
How many shares of PHAT do institutions own?
13F filers reported 75.96M shares of PHAT, worth $823.49M in aggregate at the end of 2026-Q2.
Is institutional ownership of PHAT rising or falling?
Share counts moved +1.4% versus the prior quarter — accumulation.
Who are the top institutional holders of PHAT?
The largest 13F holders are Frazier Life Sciences Management, L.P., Medicxi Ventures Management (Jersey) Ltd, Vanguard Group, JENNISON ASSOCIATES LLC, BlackRock Inc; the top 25 are ranked at the top of this page.
Who are the major shareholders of PHATHOM PHARMACEUTICALS INC?
The major shareholders of PHATHOM PHARMACEUTICALS INC (PHAT) by reported 13F value are Frazier Life Sciences Management, L.P., Medicxi Ventures Management (Jersey) Ltd, Vanguard Group, JENNISON ASSOCIATES LLC, BlackRock Inc, among 320 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.